Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of prostate
|
1082 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.100 | 0.857 | 14 | 2007 | 2016 | ||||
Prostate carcinoma
|
1168 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.100 | 0.857 | 14 | 2007 | 2016 | ||||
Breast Carcinoma
|
2793 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.100 | 0.667 | 12 | 2006 | 2018 | ||||
Malignant neoplasm of breast
|
3417 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.100 | 0.667 | 12 | 2006 | 2018 | ||||
Malignant neoplasm of lung
|
1142 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.090 | 0.889 | 9 | 2004 | 2017 | ||||
Carcinoma of lung
|
1204 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.080 | 0.875 | 8 | 2004 | 2017 | ||||
Primary malignant neoplasm of lung
|
981 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.080 | 0.875 | 8 | 2004 | 2017 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.070 | 0.857 | 7 | 2006 | 2016 | ||||
Diabetes Mellitus
|
824 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.050 | 0.600 | 5 | 2006 | 2018 | ||||
Coronary heart disease
|
1178 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.040 | 1.000 | 4 | 2010 | 2016 | ||||
Diabetes
|
710 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.040 | 0.500 | 4 | 2006 | 2018 | ||||
Liver carcinoma
|
942 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.040 | 1.000 | 4 | 2009 | 2015 | ||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.030 | 1.000 | 3 | 2007 | 2018 | ||||
Diabetic Retinopathy
|
213 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.030 | 0.667 | 3 | 2006 | 2009 | ||||
Epilepsy
|
339 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.030 | 1.000 | 3 | 2012 | 2019 | ||||
Hypercholesterolemia
|
123 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.030 | 1.000 | 3 | 2010 | 2017 | ||||
Malignant Neoplasms
|
1641 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.030 | 1.000 | 3 | 2008 | 2015 | ||||
Obesity
|
1111 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.030 | 1.000 | 3 | 2008 | 2015 | ||||
Asthma
|
1536 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.020 | 1.000 | 2 | 2004 | 2006 | ||||
Cirrhosis
|
110 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.020 | 1.000 | 2 | 2011 | 2012 | ||||
Coronary Arteriosclerosis
|
440 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.020 | 1.000 | 2 | 2010 | 2012 | ||||
Coronary Artery Disease
|
1577 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.020 | 1.000 | 2 | 2010 | 2012 | ||||
Diabetic Nephropathy
|
238 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.020 | 1.000 | 2 | 2007 | 2009 | ||||
Drug-induced tardive dyskinesia
|
67 | 0.500 | 0.840 | 6 | 159692840 | missense variant | A/G | snv | 0.48 | 0.47 | 0.020 | 0.500 | 2 | 2008 | 2010 |